University of Michigan is Awarded $21 Million Grant to Study HIV Virus Behavior
A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.
Dr. Alice Telesnitsky, professor of microbiology and immunology at the University of Michigan Medical School
A $21 million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.
The National Institutes of Health grant, which will be distributed during a five-year period, establishes the Center for HIV RNA Studies, or CRNA.
Alice Telesnitsky, PhD, a professor of microbiology and immunology at the U-M Medical School, will head the CRNA and says the grant brings together researchers in a variety of disciplines to tackle the sometimes tricky HIV-1 RNA molecule, which plays an essential role in a virus ability to reproduce itself.
Viruses are made up of proteins and RNA, and most research focuses on the proteins, she says. Because RNA is a simple molecule, it can sometimes appear nondescript when we look at it. This grant will unite a team of people who will look at RNA on different scales, assessing its structure, movement and replication.
Telesnitsky says a better understanding of RNAs biological processes could ultimately lead to innovative treatments for AIDS and other human diseases.
Researchers from Telesnitskys lab at U-M, as well as scientists from 13 other institutions across the country, will use the NIH grant to take a multidisciplinary approach to the research.
Telesnitsky says the team includes world leaders in fields such as structural biology, chemistry, cell and computation biology, molecular biology and virology.
Funding for the grant comes from the National Institute of General Medical Sciences and the NIHs National Institutes of Allergy and Infectious Diseases.
This is an absolutely outstanding group of structural biologists and virologists focused on an understudied yet critical component of the HIV virionthe genomic RNA, says Michael Sakalian, PhD, the NIGMS official who oversees the grant for the specialized center. Their efforts to elucidate the structural and functional roles of RNA in the viral life cycle will advance our fundamental understanding of host-virus interactions as well as identify potential new targets for therapeutic intervention.
Source: University of Michigan Health System
Â
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
